ArticleJournal of assisted reproduction and genetics2026
Genetic analysis, reproductive decision-making, and pregnancy outcomes in 51 Chinese osteogenesis imperfecta families.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeTo elucidate the genetic etiology of osteogenesis imperfecta (OI) in affected families and to characterize reproductive decision-making, reproductive interventions, and pregnancy outcomes of these families.
methodsFifty-one families with clinically suspected OI underwent variant analysis by Sanger sequencing or next-generation sequencing (NGS) and clinical follow-up of reproductive options and pregnancy outcomes.
resultsOf the 51 enrolled families, 37 probands had mild phenotypes and 14 presented with severe phenotypes. Genetic analysis revealed that 46 probands (90.2%) carried heterozygous variants in COL1A1 or COL1A2, and five (9.8%) harbored biallelic variants in WNT1, CRTAP, P3H1, and SERPINF1. Of the identified variants, 14 were novel. Among the 45 families with follow-up data, the proportion of couples who discontinued reproductive attempts was higher in the OI-women group than in the OI-men and normal-parent groups (35.3% vs. 5.9% and 18.2%, respectively), though the differences were not statistically significant. Both women with severe OI (n = 2) discontinued reproductive attempts, compared with 26.7% of women with mild OI. Thirty families underwent preimplantation genetic testing (PGT), which yielded 22 healthy live births. Among the remaining families, six (seven pregnancies) opted for spontaneous conception or conventional IVF with prenatal diagnosis, resulting in two terminations of affected fetuses and five healthy live births. The cesarean section rate in the OI-women group was significantly higher than that in the OI-men group (81.8% vs. 27.3%, P = 0.030), whereas the difference from the normal-parent group was not statistically significant (81.8% vs. 60.0%, P = 0.547). One woman with OI experienced reduced bone mineral density during pregnancy.
conclusionOur findings expand the OI mutational spectrum and suggest that reproductive decision-making may vary according to the sex of the affected parent, inheritance patterns, and phenotypic severity. A high cesarean section rate and skeletal complications were observed among women with OI during pregnancy, indicating that maternal and obstetric outcomes warrant careful attention in this population. Moreover, PGT was associated with healthy live births in this cohort and may reduce the likelihood of affected pregnancies in selected families.
Indexed as
Identifiers
42700360What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.